1,2,3,>=4 prior line of therapy, Relapsed Refractory Multiple Myeloma (RRMM), Daratumumab+Pomalidomide+Dexamethasone (DPd), Pomalidomide+Dexamethasone (Pd), Anti-CD38 MAb, Lenalidomide Exposed, Phase 3
### Instruction:
Identify the study with the following condition. 
### Input:
1,2,3,>=4 prior line of therapy, Relapsed Refractory Multiple Myeloma (RRMM), Daratumumab+Pomalidomide+Dexamethasone (DPd), Pomalidomide+Dexamethasone (Pd), Anti-CD38 MAb, Lenalidomide Exposed, Phase 3 
### Output:
Popular Name is APOLLO, Study ID is NCT03180736